![Matthew A. Gonda](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Matthew A. Gonda
Fondatore presso Amytrx Therapeutics, Inc.
Provenienza dei contatti di primo grado di Matthew A. Gonda
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
Amytrx Therapeutics, Inc.
![]() Amytrx Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Amytrx Therapeutics, Inc. developed biological medicines. The company was headquartered in Nashville, TN.
6
| Holding Company | Pharmaceuticals: Major | 6 |
DiscoveryBioMed, Inc.
![]() DiscoveryBioMed, Inc. BiotechnologyHealth Technology DiscoveryBioMed, Inc. provides human cell-based drug discovery services. It provides pilot screening and high-throughput screening services for therapeutic-related bioassays, custom immortalized cell lines and therapeutics discovery for certain failure-to-secrete diseases in humans. The company was founded by Erik M. Schwiebert in October 2007 and is headquartered in Birmingham, AL.
5
| Subsidiary | Biotechnology | 5 |
Genovo, Inc.
![]() Genovo, Inc. Medical SpecialtiesHealth Technology Part of Innoviva, Inc., Genovo, Inc. is a maker of gene and cell therapy products. The company is based in Sharon Hill, PA. Genovo was acquired by AmpliPhi Biosciences Corp. on September 20, 2000 for $84.53 million.
2
| Subsidiary | Medical Specialties | 2 |
TransMolecular, Inc.
![]() TransMolecular, Inc. BiotechnologyHealth Technology TransMolecular is an oncology-focused biotechnology company committed to developing novel proprietary drugs to diagnose and treat human diseases using a novel tumor targeting platform called TM601. Their development program to date has explored the therapeutic use of TM601 in cancer and neovascular diseases of the eye, and their lead candidate, TM601 conjugated to the radioactive isotope 131I, has a Special Protocol Agreement (SPA) with the FDA for a pivotal, Phase 3 trial in newly diagnosed glioblastoma multiforme (glioma). TM601 has unique properties of highly specific tumor cell binding and internalization while not affecting normal cells, targeting both primary disease sites and metastases. The interaction of TM601 with a specific protein known to be over-expressed on the surface of tumor cells and vascular endothelium is implicated in these tumor-specific binding properties. Conjugated to an anti-cancer radioactive isotope, TM601 has been successful in human and animal models in demonstrating selective targeting and uptake in a number of different tumor types, and in tumor locations within the central nervous system (CNS) and peripherally. Expanded research confirms that TM601 can deliver a variety of conjugates, creating potential for development of a wide array of anti-cancer therapies. In addition to the tumor targeting capability of TM601, a number of studies have also revealed that TM0601 exerts robust anti-angiogenic effects on vessels associated with neovascular disease. Pursuing this anti-angiogenic potential further, They have also determined the utility of TM601 in animal ophthalmic models. The company is leveraging its platform in strategic collaborations with partners seeking to expand product pipelines, extend product life-cycles for existing anti-tumor compounds, or optimize therapeutic activity of marginally effective or restrictively toxic drugs.
1
| Extinct | Biotechnology | 1 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Matthew A. Gonda tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
TheraTech, Inc.
![]() TheraTech, Inc. Medical DistributorsDistribution Services TheraTech, Inc. manufactures and distributes medical devices. The company was founded by Chick Sanford & Dinesh C. Patel in January, 1985 and is located in Hopkins, MN | Medical Distributors | Director/Board Member | |
Orchestra Therapeutics, Inc.
![]() Orchestra Therapeutics, Inc. Financial ConglomeratesFinance Orchestra Therapeutics, Inc. operates as a development stage company. It previously operated as an immuno-pharmaceutical company focused on developing products to treat autoimmune diseases. The company was founded in 1986 and is headquartered in Carlsbad, CA. | Financial Conglomerates | Founder | |
AMARIN CORPORATION PLC | Pharmaceuticals: Major | Director/Board Member | |
AVANIR PHARMACEUTICALS INC | Pharmaceuticals: Major | Director/Board Member | |
3-Dimensional Pharmaceuticals, Inc.
![]() 3-Dimensional Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology 3-Dimensional Pharmaceuticals, Inc. was acquired by Johnson & Johnson. 3-Dimensional Pharmaceuticals, Inc. operates as a drug discovery and development company that has a pipeline of drug candidates in the areas of cancer and inflammation, and metabolic and cardiovascular diseases | Pharmaceuticals: Major | Director/Board Member | |
Avondale Partners LLC
![]() Avondale Partners LLC Investment Banks/BrokersFinance Avondale Partners LLC is an independent broker/dealer headquartered in Nashville, Tennessee with additional offices across the US. The firm was founded by Robert Shepherd and Philip Krebs in 2001. Avondale Partners provides financial advisory services as well as equity and fixed income underwriting and private placement services to public and private companies throughout the US, Canada and Europe. They focus on middle-market companies in the healthcare sector. | Investment Banks/Brokers | Founder | |
CardioKine, Inc.
![]() CardioKine, Inc. Pharmaceuticals: MajorHealth Technology CardioKine, Inc. develops drugs and pharmaceuticals for the treatment and prevention of heart failure. The company was founded by Arthur Michael Feldman, James Mervis, Paul-Andre de Lame and Michael Juliano in 2004 and is headquartered in Pittsburgh, PA. | Pharmaceuticals: Major | Director/Board Member | |
SkinMedica, Inc.
![]() SkinMedica, Inc. Medical DistributorsDistribution Services SkinMedica, Inc. is a specialty skin care pharmaceutical company. It develops, acquires, and commercializes products for treatment of dermatologic conditions and improvement of skin appearance. It markets and sells to physicians, with a focus on aesthetics, both prescriptions and non-prescription skin care products. SkinMedica was founded in May 1999. Its company headquarters are located in Carlsbad, California. Company already EXT. Filed in HOL tracker. | Medical Distributors | Director/Board Member | |
Aisling Capital LLC
![]() Aisling Capital LLC Investment ManagersFinance Aisling Capital LLC (Aisling Capital) is an venture capital firm founded in 1999 by Dennis Joseph Purcell. The firm is headquartered in New York, New York. | Investment Managers | Private Equity Investor | |
CytoViva, Inc.
![]() CytoViva, Inc. Medical SpecialtiesHealth Technology CytoViva, Inc. provides optical microscopy-imaging systems. Its products include hyperspectral micropscopy, enhanced darkfield micropscopy and three dimensional enhanced darkfield microscopy. The company was founded by Samuel M. Lawrence and John O. Lawrence in 2005 and is headquartered in Auburn, AL. | Medical Specialties | Director/Board Member | |
PNP Therapeutics, Inc.
![]() PNP Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology PNP Therapeutics, Inc. operates as a biopharmaceutical company which develops a platform technology and proprietary products for the treatment of cancer. It offers E. coli purine nucleoside phosphorylase that work with nucleoside prodrugs generating active metabolites with anti-tumor activity. The company was founded by William B. Parker and Eric J. Sorscher and is headquartered in Birmingham, AL. | Pharmaceuticals: Major | Director/Board Member | |
INVITAE CORPORATION | Medical/Nursing Services | Director/Board Member | |
Dunn Investment Co., Inc.
![]() Dunn Investment Co., Inc. Financial ConglomeratesFinance Dunn Investment Co., Inc. is a private company that specializes in asphalt and aggregates. Dunn Construction has five plants located in the greater Birmingham and surrounding areas, offering a wide variety of asphalt products suited for any need or application. The company is based in Birmingham, AL and has subsidiaries in the United States. The company has a vertically integrated approach to asphalt production and paving, as well as their own aggregate operation. The company has five paving crews, one milling crew, and three base crews, which allows them to carry out jobs of any size. The company also prioritizes community service and giving back to their community. | Financial Conglomerates | Chief Investment Officer | |
HealthCare Ventures LLC
![]() HealthCare Ventures LLC Investment ManagersFinance HealthCare Ventures LLC (HealthCare Ventures) is a venture capital firm founded in 1985 by Harold R. Werner. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Chief Investment Officer | |
Dartmouth College | College/University | Doctorate Degree | |
UNIFIEDONLINE INC | Data Processing Services | Director/Board Member | |
Southern BioSystems, Inc.
![]() Southern BioSystems, Inc. Medical SpecialtiesHealth Technology Part of DURECT Corp., Southern BioSystems, Inc. is a company that manufactures and develops biodegradable polymer and non-polymer drug delivery systems. The company is based in Birmingham, AL. The company was founded by Alan H. Dean. Southern BioSystems was acquired by DURECT Corp. on April 30, 2001 for $13.64 million. | Medical Specialties | Chairman | |
Amarin Pharmaceuticals, Inc.
![]() Amarin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of Bausch Health Cos., Inc., Amarin Pharmaceuticals, Inc. is a pharmaceutical company that manufactures and develops pharmaceuticals. The company is based in Mill Valley, CA. | Pharmaceuticals: Major | Director/Board Member | |
Grinnell College | College/University | Undergraduate Degree | |
Cornell University
![]() Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Undergraduate Degree | |
The University of Alabama | College/University | Graduate Degree Corporate Officer/Principal Corporate Officer/Principal | |
University of Idaho | College/University | Doctorate Degree | |
University of Northern Iowa | College/University | Undergraduate Degree | |
Council on Foreign Relations, Inc.
![]() Council on Foreign Relations, Inc. Investment Trusts/Mutual FundsMiscellaneous Council on Foreign Relations, Inc. provides and disseminates ideas on foreign policies to individuals, corporate members, journalists and policy makers. It operates a forum for government officials, students and other interested parties to study and discuss world issues and impact on American foreign policies. The company publishes Foreign Affairs, a magazine that comes out six times a year, along with books and studies by its own scholars. Council on Foreign Relations was founded in 1921 and is headquartered in New York City, NY. | Investment Trusts/Mutual Funds | Corporate Officer/Principal | |
Claridge Co. LLC | Founder | ||
The University of Alabama at Birmingham | College/University | Doctorate Degree | |
Intuity Medical, Inc.
![]() Intuity Medical, Inc. Medical SpecialtiesHealth Technology Intuity Medical, Inc. develops a blood glucose monitoring system for diabetic patients. The firm offers POGO Automatic, an automated, self-contained handheld monitor that enables patients to measure blood glucose levels within seconds. It also offer Patterns, an application which centralizes each patient?s blood glucose testing data in a digital form that can be shared with healthcare providers. The company was founded by Syrous Parsay on April 24, 2002 and is headquartered in Fremont, CA. | Medical Specialties | Director/Board Member | |
Harvard Medical School | College/University | Doctorate Degree | |
Locus Development, Inc.
![]() Locus Development, Inc. Real Estate DevelopmentFinance Locus Development, Inc. provides real estate development and asset management services. The company was founded by Sean E. George in in 2010 and is headquartered in Grand Rapids, MI. | Real Estate Development | Director/Board Member | |
Adamis Viral Therapies, Inc. | Chief Executive Officer | ||
Adamis Corp. | Chief Executive Officer | ||
BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD. | Pharmaceuticals: Major | Director/Board Member | |
Tufts University School of Medicine | College/University | Corporate Officer/Principal | |
BridgeBio Pharma LLC
![]() BridgeBio Pharma LLC BiotechnologyHealth Technology BridgeBio Pharma LLC engages in the discovery and development of pharmaceutical drugs for patients with genetic diseases. It offers transthyretin stabilizer, SHP2 inhibitor, KRAS inhibitor, Collagen 7 replacement, and S1P-lyase inhibitor. The company was founded by Neil Kumar and is headquartered in Palo Alto, CA. | Biotechnology | Director/Board Member | |
Philadelphia Ventures, Inc.
![]() Philadelphia Ventures, Inc. Investment ManagersFinance Philadelphia Ventures Inc (Philadelphia Ventures) was a venture capital firm founded in 1967 by Norley Michael. The firm was headquartered in Philadelphia, Pennsylvania. | Investment Managers | Corporate Officer/Principal | |
EIDOS THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
BRIDGEBIO PHARMA, INC. | Biotechnology | Director/Board Member | |
BIOMEA FUSION, INC. | Pharmaceuticals: Major | Director/Board Member | |
Garuda Therapeutics, Inc.
![]() Garuda Therapeutics, Inc. BiotechnologyHealth Technology Garuda Therapeutics, Inc. aims to eliminate the need for donor or patient cells for blood stem cell transplants. The company is based in Natick, MA. The company's platform technology generates off-the-shelf, self-renewing blood stem cells that are HLA-compatible and transgene-free. This technology could potentially provide curative therapies for over 120 diseases. Garuda Therapeutics was founded by Dhvanit Shah, Sean Morrison, and David T. Scadden, with Dhvanit Shah serving as CEO since incorporation. | Biotechnology | Director/Board Member | |
BIOHAVEN LTD. | Pharmaceuticals: Major | Director/Board Member | |
Adamis Laboratories, Inc.
![]() Adamis Laboratories, Inc. Medical DistributorsDistribution Services Part of DMK Pharmaceuticals Corp., Adamis Laboratories, Inc. distributes respiratory products. The company is based in Boca Raton, FL. The CEO of the company is Dennis J. Carlo. | Medical Distributors | Chief Executive Officer |
Statistiche
Distribuzione geografica
Stati Uniti | 48 |
Irlanda | 2 |
Messico | 2 |
Settori
Health Technology | 20 |
Finance | 10 |
Consumer Services | 10 |
Distribution Services | 6 |
Technology Services | 3 |
Posizioni
Director/Board Member | 53 |
Corporate Officer/Principal | 15 |
Independent Dir/Board Member | 10 |
Chief Executive Officer | 8 |
Undergraduate Degree | 8 |
Contatti più connessi
- Borsa valori
- Insiders
- Matthew A. Gonda
- Connessioni Società